These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9139496)

  • 1. Replication and immunogenicity of Ad7-, Ad4-, and Ad5-hepatitis B virus surface antigen recombinants, with or without a portion of E3 region, in chimpanzees.
    Chengalvala MV; Bhat BM; Bhat RA; Dheer SK; Lubeck MD; Purcell RH; Murthy KK
    Vaccine; 1997 Feb; 15(3):335-9. PubMed ID: 9139496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of high expression adenovirus-hepatitis B virus recombinant vaccines in dogs.
    Chengalvala MV; Bhat BM; Bhat R; Lubeck MD; Mizutani S; Davis AR; Hung PP
    J Gen Virol; 1994 Jan; 75 ( Pt 1)():125-31. PubMed ID: 8113721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of adenovirus type 4 and type 7 recombinant hepatitis B vaccines in dogs.
    Chengalvala M; Lubeck MD; Davis AR; Mizutani S; Molnar-Kimber K; Morin J; Hung PP
    Vaccine; 1991 Jul; 9(7):485-90. PubMed ID: 1832806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant adenovirus induces antibody response to hepatitis B virus surface antigen in hamsters.
    Morin JE; Lubeck MD; Barton JE; Conley AJ; Davis AR; Hung PP
    Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4626-30. PubMed ID: 2955413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus vectored vaccines.
    Natuk RJ; Davis AR; Chanda PK; Lubeck MD; Chengalvala M; Murthy SC; Wade MS; Dheer SK; Bhat BM; Murthy KK
    Dev Biol Stand; 1994; 82():71-7. PubMed ID: 7958485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirus.
    Lubeck MD; Davis AR; Chengalvala M; Natuk RJ; Morin JE; Molnar-Kimber K; Mason BB; Bhat BM; Mizutani S; Hung PP
    Proc Natl Acad Sci U S A; 1989 Sep; 86(17):6763-7. PubMed ID: 2570422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus vaccine vectors expressing hepatitis B surface antigen: importance of regulatory elements in the adenovirus major late intron.
    Mason BB; Davis AR; Bhat BM; Chengalvala M; Lubeck MD; Zandle G; Kostek B; Cholodofsky S; Dheer S; Molnar-Kimber K
    Virology; 1990 Aug; 177(2):452-61. PubMed ID: 2371766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early region 3-replacement adenovirus recombinants are less pathogenic in cotton rats and mice than early region 3-deleted viruses.
    Berencsi K; Uri A; Valyi-Nagy T; Valyi-Nagy I; Meignier B; Peretz FV; Rando RF; Plotkin SA; Gönczöl E
    Lab Invest; 1994 Sep; 71(3):350-8. PubMed ID: 7933985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective and nondefective adenovirus vectors for expressing foreign genes in vitro and in vivo.
    Levrero M; Barban V; Manteca S; Ballay A; Balsamo C; Avantaggiati ML; Natoli G; Skellekens H; Tiollais P; Perricaudet M
    Gene; 1991 May; 101(2):195-202. PubMed ID: 1829048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing of CpG-optimized protein and DNA vaccines against the hepatitis B virus in chimpanzees for immunogenicity and protection from challenge.
    Payette PJ; Ma X; Weeratna RD; McCluskie MJ; Shapiro M; Engle RE; Davis HL; Purcell RH
    Intervirology; 2006; 49(3):144-51. PubMed ID: 16428890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of adenovirus-vectored respiratory syncytial virus vaccines in a new ferret model.
    Hsu KH; Lubeck MD; Bhat BM; Bhat RA; Kostek B; Selling BH; Mizutani S; Davis AR; Hung PP
    Vaccine; 1994 May; 12(7):607-12. PubMed ID: 8085377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-expression of hepatitis B virus antigens by a non-defective adenovirus vaccine vector.
    Ye WW; Mason BB; Chengalvala M; Cheng SM; Zandle G; Lubeck MD; Lee SG; Mizutani S; Davis AR; Hung PP
    Arch Virol; 1991; 118(1-2):11-27. PubMed ID: 1828660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+ T Cells Are Not Required for Suppression of Hepatitis B Virus Replication in the Liver of Vaccinated Chimpanzees.
    Rybczynska J; Campbell K; Kamili S; Locarnini S; Krawczynski K; Walker CM
    J Infect Dis; 2016 Jan; 213(1):49-56. PubMed ID: 26324781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial safety and immunogenicity studies of an oral recombinant adenohepatitis B vaccine.
    Tacket CO; Losonsky G; Lubeck MD; Davis AR; Mizutani S; Horwith G; Hung P; Edelman R; Levine MM
    Vaccine; 1992; 10(10):673-6. PubMed ID: 1523878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
    Chen Y; Xiong X; Liu X; Li J; Wen Y; Chen Y; Dai Q; Cao Z; Yu W
    Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA-mediated immunization to the hepatitis B surface antigen. Activation and entrainment of the immune response.
    Whalen RG; Leclerc C; Dériaud E; Schirmbeck R; Reimann J; Davis HL
    Ann N Y Acad Sci; 1995 Nov; 772():64-76. PubMed ID: 8546414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of vaccinia virus-expressed adenovirus E3-19K glycoprotein with class I MHC and its effects on virulence in a murine pneumonia model.
    Grunhaus A; Cho S; Horwitz MS
    Virology; 1994 May; 200(2):535-46. PubMed ID: 8178441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutated epitopes of hepatitis B surface antigen fused to the core antigen of the virus induce antibodies that react with the native surface antigen.
    Shiau AL; Murray K
    J Med Virol; 1997 Mar; 51(3):159-66. PubMed ID: 9139078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [DNA cloning of Ad7 vaccine strain and sequence analysis of its Sma I H fragment].
    Zhou J; Qu J; Shi C
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Mar; 12(1):23-5. PubMed ID: 12515165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus type 4 and 7 vaccination or adenovirus type 4 respiratory infection elicits minimal cross-reactive antibody responses to nonhuman adenovirus vaccine vectors.
    Paris R; Kuschner RA; Binn L; Thomas SJ; Colloca S; Nicosia A; Cortese R; Bailer RT; Sullivan N; Koup RA
    Clin Vaccine Immunol; 2014 May; 21(5):783-6. PubMed ID: 24623627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.